Abstract
These results suggest desmosomal proteins, and in particular desmoglein 2, may function as receptors of eFABP4 and provide new insight into the development and progression of obesity-associated cancers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have